Yiming Cai Selected Research

Yiming Cai Research Topics

3	Neoplasms (Cancer) 02/2023 - 01/2021
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2024 - 02/2024
2	Ischemic Stroke 03/2024 - 02/2024
2	Stroke (Strokes) 03/2024 - 02/2024
2	Infections 01/2020 - 01/2020
2	COVID-19 01/2020 - 01/2020
1	Pathologic Constriction (Stenosis) 03/2024
1	Hemorrhage 03/2024
1	Myocardial Infarction 03/2024
1	Transient Ischemic Attack 03/2024
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2023
1	Lymphoma (Lymphomas) 01/2022
1	Multiple Myeloma 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Tuberculosis (Tuberculoses) 01/2020

2	Histone DemethylasesIBA 02/2023 - 01/2023
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2020
1	indobufenIBA 03/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2024
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2024
1	Clopidogrel (Plavix)FDA Link 03/2024
1	LipidsIBA 02/2024
1	antineoplaston A10 (A 10)IBA 02/2024
1	oxidized low density lipoproteinIBA 02/2024
1	Rosuvastatin Calcium (Crestor)FDA Link 02/2024
1	Atorvastatin (Lipitor)FDA Link 02/2024
1	Ezetimibe (Zetia)FDA Link 02/2024
1	TabletsIBA 02/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024
1	SteroidsIBA 10/2023
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	dinutuximabIBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	CytokinesIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	EnzymesIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	AntitoxinsIBA 01/2020
1	Casein Kinase II (Casein Kinase 2)IBA 01/2020
1	Bacterial ToxinsIBA 01/2020
1	VaccinesIBA 01/2020
1	Viral ProteinsIBA 01/2020

6	Therapeutics 03/2024 - 01/2020
1	Salvage Therapy 10/2023
1	Hematopoietic Stem Cell Transplantation 10/2023
1	Drug Therapy (Chemotherapy) 01/2021